HAE Earnings

HAE reported its earnings on 2026-05-07, showcasing a revenue of 346.35M against an estimate of 338.14M, resulting in a 2.43% surprise. The EPS was 1.29, surpassing the expected 1.28 by 0.78%. The stock experienced a 3.23% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following HAE's earnings announcement on 2026-05-07, the stock price moved by 3.23% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, HAE's stock price tends to shift by an average of 5.71% in the 10 days leading up to earnings and -0.52% in the 10 days following, providing insight into potential market.

For 2026/Q4, analysts estimate HAE's annual revenue to reach 337.42M, while the EPS is projected at 1.30. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HAE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HAE's stock price typically moves by 5.71% in the 10 days before its earnings and -0.52% in the 10 days after. For the upcoming 2026/Q4 earnings, analysts expect an EPS of 1.30 and revenue of 337.42M.

The earnings call summary indicates positive sentiment with raised revenue guidance, improved organic growth projections, and an increase in adjusted EPS. Despite a slight decline in Q4 operating margins, the full-year margin improved. The Q&A section highlighted strong plasma market growth and potential upside from Persona PLUS. While there are concerns over tariffs and plasma growth, the overall outlook remains optimistic. Given the market cap of approximately $4.2 billion, the stock price is likely to react positively, falling within the 2% to 8% range over the next two weeks.